GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend Research & Listing Availability
Current GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend vial offers are unavailable in this comparison. Research information remains available; this does not establish permanent discontinuation.
Current GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend vial offers are unavailable in this comparison. Research information remains available; this does not establish permanent discontinuation.
About GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend
Pre-clinical / research-onlyThis is a six-part research blend combining growth-hormone secretagogues (GHRP-2, Tesamorelin, Ipamorelin) with MGF, Follistatin 344, and IGF-1 LR3, sourced for muscle and recovery research. No human trial of the combination exists; it ships as a lyophilized powder.
What to check before you buy GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend:
- A COA that confirms ALL SIX components individually by mass-spec — not a single combined "blend tested" line.
- The stated amount of each component on a COA dated within the last 6–12 months for that batch. Off-ratio blends are common when one component is cheaper to include.
- Accurate total fill matching the label so each component lands where your math says. An under-filled blend vial skews every dose at once.
The individual components have mostly animal or early-stage literature, summarized in their standalone entries. The blend itself has no published human trial.
Regulatory: Not FDA-approved. No human trial of the combination exists; sold as research-grade material for non-clinical use.
Sources & references (1)
Peer-reviewed literature, FDA documents, and trial registrations cited above. Vendor pricing, COA data, and live calculator statistics shown elsewhere on this page are sourced from the WPA database independently of this list.
- [1]Manufacturer product label; component literature (see individual compound entries).
GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend Calculator Input Observations
There is insufficient calculator evidence here to describe a common GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend entered amount. Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length.
About GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend
This is a six-part research blend combining growth-hormone secretagogues (GHRP-2, Tesamorelin, Ipamorelin) with MGF, Follistatin 344, and IGF-1 LR3, sourced for muscle and recovery research. No human trial of the combination exists; it ships as a lyophilized powder.
GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend is a blend of Follistatin 344, GHRP-2, IGF-1 LR3, Ipamorelin, MGF, and Tesamorelin, so a COA has to confirm each component separately — a single purity figure for the mixture is not enough. Not FDA-approved.
Frequently Asked Questions: GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend
Are current GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend offers available?
Current GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend vial offers are unavailable in this comparison. Research information remains available; this does not establish permanent discontinuation.
What can I check if GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend listings become available?
Check the exact compound, format, labelled quantity, named laboratory, test date, and batch match. Confirm any future listing price, discount terms, and stock directly with the vendor. Catalog COA fields alone are not independent verification.
Does research activity establish current GHRP-2/Tesamorelin/MGF/Ipamorelin/Follistatin 344/IGF-1 LR3 Blend availability?
No. Search interest, calculator entries, historical prices, related compounds, and other formats do not establish current offers in this comparison. Research information and navigation to other compounds remain available.